JPRN-jRCT2080224538已完成3 期
Efficacy and safety of LEO 90100 foam in Japanese subjects with psoriasis vulgaris
EO Pharma K.K.0 个研究点目标入组 182 人开始时间: 2019年1月31日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 182
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Japanese subjects aged 20 years or more
- •2.Clinical diagnosis of psoriasis vulgaris of less than or equal to 30% BSA (excluding any psoriasis on the face, skin folds, genitals)
- •3.A target psoriasis lesion on the body, of a minimum size of 10 cm2 and scoring at least 2 (mild) for each of redness, thickness and scaliness
- •4.Females of childbearing potential must have a negative result for a urine pregnancy test at Day 1 (Visit 1) and must agree to use an adequate method of birth control
排除标准
- •1. Use of systemic treatment with an effect on psoriaisis
- •2. Use of UV therapy on full body or on the target lesion
- •3. Use of topical treatment on areas to be treated with trial medication
- •4. Topical treatment on areas other than treated areas with vitamin D
- •analogues, immunosuppressants or strong/very strong corticosteroids
- •5. Skin diseases besides psoriasis on the areas to be treated with trial medication.
- •6. Disorders of calcium metabolism, hypercalcaemia, renal insufficiency, hepatic disorders, heart disease.
研究者
相似试验
已完成
3 期
Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis VulgarisPsoriasis VulgarisNCT03806790LEO Pharma182
已完成
1 期
Dermatopharmacokinetic Trial of LEO 90100 FoamHealthyNCT03476746LEO Pharma58
进行中（未招募）
1 期
A research Study to evaluate the efficacy and safety of LEO 90100 aerosol foam for adolescent patients with plague psoriasisEUCTR2015-000839-33-NLEO Pharma A/S100
已完成
2 期
Safety and Effect of LEO 90100 aerosol foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) with Plaque Psoriasis A phase 2 trial evaluating the safety and efficacy of once daily topical treatment with LEO 90100 aerosol foam in adolescent subjects with plaque psoriasisPsoriasis10014982Plaque PsoriasisNL-OMON42757eo Pharma15
进行中（未招募）
1 期
A research Study to evaluate the efficacy and safety of LEO 90100 aerosol foam for adolescent patients with plague psoriasisPlague PsoriasisMedDRA version: 20.0Level: LLTClassification code 10050576Term: Psoriasis vulgarisSystem Organ Class: 100000004858EUCTR2015-000839-33-PLEO Pharma A/S100